Bio­gen CEO Chris Viehbach­er: Im­munol­o­gy is a nat­ur­al fit at biotech, calls for 'rein­ven­tion'

From Chris Viehbach­er’s van­tage point, Bio­gen was nev­er re­al­ly a neu­ro­science com­pa­ny.

Bio­gen has launched a sig­nif­i­cant re­vamp un­der Viehbach­er, in­clud­ing the re­cent hire of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER